Johnson & Johnson – The US healthcare giant receives FDA approval for its surgical robot Ottava!
Reading Time: 3 minutes
Johnson & Johnson receives FDA approval for its surgical robot Ottava – initially for upper abdominal procedures such as gastric bypass surgeries. The uniqueness: four robot arms, integrated directly into the operating table, saving 30–50% space. J&J is thus challenging the market leader Intuitive Surgical (Da Vinci), but remains a latecomer. A milestone after years of development Johnson & Johnson celebrates a significant breakthrough in medical technology: after more than a decade of research and years of delays, the company...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

